Brief: Natco Pharma Announces Approval Of ANDA For Everolimus Tablets
30/01/2025 04:10
Jan 30 (Reuters) - Natco Pharma Ltd NATP.NS :
* NATCO PHARMA - ANNOUNCES APPROVAL OF ANDA FOR EVEROLIMUS
TABLETS
* NATCO PHARMA - BRECKENRIDGE PHARMACEUTICAL TO LAUNCH
PRODUCT
IMMEDIATELY IN US
Source text: ID:nBSESdMF
Further company coverage: NATP.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Natco Pharma
See all newsBrief: Natco Pharma Launches Carboplatin Injection In Us With Teyro Labs
India's Natco Pharma jumps after launching ovarian cancer drug in US
Brief: Natco Pharma Announces Launch Of Carboplatin Injection In The U.S. Market
Brief: Natco Pharma To Increase Its Investment In Egenesis To $16.70 Million
Brief: Natco Pharma Approves Rights Issue Up To 12.79 Billion Rupees